Retinoblastoma and vision

The assessment of vision has a growing importance in the management of retinoblastoma in the era of globe-conserving therapy, both prior to and after treatment. As survival rates approach 98-99% and globe salvage rates reach ever-higher levels, it is important to provide families with information regarding the visual outcomes of different treatments. We present an overview of the role of vision in determining the treatment given and the impact of complications of treatment. We also discuss screening and treatment strategies that can be used to maximise vision.

Automated summary

The assessment of vision plays an increasingly important role in the management of retinoblastoma in the era of globe-conserving therapy. It is crucial to provide families with information on the visual outcomes of different treatments, as survival rates improve and globe salvage rates increase. This article provides an overview of the role of vision in determining treatment and the impact of treatment complications, as well as discussing screening and treatment strategies to maximize vision.